QL
TSHA icon

Quarry LP’s Taysha Gene Therapies TSHA Stock Holding History

Quarry LP’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27K Buy
+480
New +$2.84K ﹤0.01% 1322
2024
Q2 		– Sell
-10,000
Closed -$28.7K – 2104
2024
Q1 		$28.7K Buy
10,000
+2,000
+25% +$4.17K 0.01% 743
2023
Q4 		$14.2K Buy
+8,000
New +$15.9K ﹤0.01% 938

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quarry LP's TSHA Position: Q2 2026 in Review

Quarry LP opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 480 shares worth $3.27K. The stake represents ﹤0.01% of the portfolio and ranks #1322 among its holdings. This is a return to the name: Quarry LP previously reported a position in TSHA as recently as Q1 2024.

Quarry LP first reported a position in TSHA in Q4 2023 and has held it in 3 quarters since. The position peaked at $28.7K in Q1 2024. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Quarry LP held 480 shares of Taysha Gene Therapies worth $3.27K as of Q2 2026.
  • Taysha Gene Therapies was a new Quarry LP position in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1322 holding.
  • Quarry LP first reported a position in Taysha Gene Therapies in Q4 2023 and has held it in 3 quarters since.
  • Quarry LP's Taysha Gene Therapies position peaked at $28.7K in Q1 2024.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.